Amalgamated Bank Merrimack Pharmaceuticals Inc Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$13.06 - $15.0 $14,744 - $16,935
-1,129 Reduced 76.18%
353 $5,000
Q4 2023

Feb 06, 2024
SELL
$12.02 - $13.41 $1,262 - $1,408
-105 Reduced 6.62%
1,482 $20,000
Q2 2023

Aug 11, 2023
BUY
$12.02 - $13.07 $19,075 - $20,742
1,587 New
1,587 $19,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email